Who Should Consider GLP-1 Drugs And Who Shouldn't Good Candidates BMI 30+ (obese) The primary indication for all weight-management GLP-1s BMI 27+ with a weight-related condition (diabetes, high blood pressure, sleep apnea, PCOS, fatty liver) Failed sustained weight loss through diet and exercise alone for 6+ months Pre-diabetic GLP-1s can prevent progression to Type 2 diabetes Cardiovascular risk Semaglutide specifically has proven heart protection Not Appropriate For Cosmetic weight loss of a few kilograms These are serious medications, not diet pills History of medullary thyroid cancer or MEN2 syndrome Absolute contraindication History of pancreatitis Relative contraindication
Cell dissociation for single cell RNA sequencing Hypothalamic progenitors were re-plated onto 6-well or 12-well polystyrene plates (Corning) for scRNAseq experiment
Macros and nutrition on keto with semaglutide Standard ketogenic macro ratios are approximately 55 to 60 percent of calories from fat, 30 to 35 percent from protein, and 5 to 10 percent from carbohydrates
Treatment discontinuation was assumed for patients not responding to treatment (i.e
Statistical analyses were performed using SPSS ver
There are at least 15 genes implicated in the conversion of cells from normal to cancerous
